Holgerl Gieschen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Experts delineate the latest developments and lingering questions in bladder and renal cancers, covering pivotal trials, emerging therapies, and optimal management approaches.

Vanderbilt universityUnited statesUniversity of tennesseeNikhil gopalDaniel vaenaEnfortumab vedotinBradleyg somerKathryne beckermannHolgerl gieschenDivision of hematologyDepartment of urologyUniversity of tennessee health science centerDepartment of medicineCancer center research instituteCancer councilCollege of medicine